Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effectsPeter A. McSweeney, Rainer Storb, Dietger Niederwieser et al.|Blood|2001Cited by 1.4k
Rituximab in B-Cell Hematologic Malignancies: A Review of 20 Years of Clinical ExperienceGilles Salles, David G. Maloney|Advances in Therapy|2017Cited by 603
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial resultsBrian G. Till, Oliver W. Press, Michael C. Jensen et al.|Blood|2012Cited by 530
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myelomaDavid G. Maloney, Rainer Storb, Frederick R. Appelbaum et al.|Blood|2003Cited by 407
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic MalignanciesMohamed L. Sorror, Rainer Storb, Brenda M. Sandmaier et al.|JAMA|2011Cited by 320